PERITONEAL DIALYSIS INTERNATIONAL, cilt.25, sa.6, ss.596-600, 2005 (SCI-Expanded)
Objectives: The aim of this study was to evaluate hepatic subcapsular steatosis (HSS) and its association with clinical parameters in nondiabetic continuous ambulatory peritoneal dialysis (CAPD) patients and in diabetic CAPD patients receiving intraperitoneal (IP) or subcutaneous (SC) insulin.